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ABSTRACT
Next Generation Sequencing (NGS) technology is emerging as an appealing tool in char-
acterizing genomic proles of target population. However, the high sequencing expense and
bioinformatic complexity will continue to be obstacles for many biomedical projects in the
foreseeable future. Modelling of NGS data not only involves sample size and genome-wide
power inference, but also includes consideration of sequencing depth and count data property.
Given total budget and pre-specied cost parameters such as unit sequencing and sample
collection, researchers usually seek for a two-dimensional optimal decision.
In this dissertation, I will introduce a novel method SeqDEsign, which is developed to
predict genome-wide power (EDR) of detecting dierential expression (DE) genes in RNA-
Seq experiment under targeted sample size (N') and read depth (R') given a pilot data (N,R).
We aimed at providing advice for researchers regarding the design of RNA-Seq experiment
with a limited budget.
The rst part of this dissertation is about predicting genome-wide power at N' with R
being xed. The pipeline started with hypothesis test for dierential expressed gene detection
based on Wald test and negative binomial assumption. We proposed ways to directly model
p-value distribution by both parametric and semi-parametric mixture model. To predict
the genome-wide power of DE gene detection at N, posterior approaches based on either
parametric or non-parametric model were implemented.
iv
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In the second part, we discussed ways to extend power prediction to N' and R' simul-
taneously. Both nested down-sampling (NDS) scheme and model-based (MB) method were
proposed and compared. The three-dimensional EDR surface (Pow(N',R')) was constructed
by two-way inverse power law model.
Finally, we discussed the cost-benet analysis of RNA-Seq experiment with specication
of a cost function. We also explored answers to other practical questions for experimental
design. This framework was illustrated in both simulations and a real data application of
rat RNA-Seq data.
The public health relevance of this work lies in the development of a novel methodol-
ogy for genome-wide power calculation of RNA-Seq experiment. By accurately predicting
genome-wide power, researchers can detect more biologically meaningful bio-markers, which
will promote better understanding of human disease.
Keywords: Next Generation Sequencing(NGS), RNA-Seq data, Power calculation, Sample
size, Mixture model, Cost-benet analysis, Experiment design.
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1.0 INTRODUCTION
With the advances in robotics and the vastly available genomic information on public
databases, microarray technology gained tremendous popularity for its high-throughput
quantitative representation and cost-eectiveness since last decade[Reimers, 2010]. While
microarray experiment provides access for biologist to a range of applications, statistical
analysis has played an active and signicant role in the whole process. Statisticians corre-
spondingly, have taken enthusiastic interests in developing statistical tools that led to more
profound biological interpretations for certain research questions[Slonim and Yanai, 2009,
Keer and Churchill, 2001]. The next-generation sequencing, which is based on random am-
plication and shotgun sequencing, is another revolutionary technology rst came to market
in 2004, making genomic proles available in much higher resolution and in extremely high
parallel[Fang and Cui, 2011]. Although errors and biases might be involved in major steps of
experimental preparation processes, next-generation sequencing has been hailed as the future
of genomic research because of its higher sensitivity and potential of generating unlimited
dynamic ranges. In this sense, research is gradually transiting from microarray technologies
to next-generation sequencing[Shendure, 2008]. From statistical point of view, some method-
ologies developed under the microarray context may still be extended to NGS, however we
are facing many new challenges in data analysis.
In a biological study, the procedure of exploring a research topic usually starts from an
experimental design, where a major component is sample size and power calculation. The
purpose of such careful design is obvious: to improve eciency and reduce cost. Methods
for power and sample size calculation in clinical and microarray data are rich in the liter-
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ature[Lee and Whitemore, 2002, Gadbury et al., 2004]. But methods for sequencing data
are very limited. As sequencing technology is still not quite aordable to the majority of
researchers, it's signicant to ensure desirable power of bio-marker detection (usually a Dif-
ferential expression(DE) analysis) in the earlier phase of study (herein called \pilot study").
In this introduction section, we will rst clarify the signicance of quantifying gene ex-
pression and go over both traditional and novel biotechnology. After that, we will introduce
the structure of a typical gene expression data and review methods of dierential expres-
sion analysis. Furthermore, we will distinguish between traditional power and genome-wide
power denition and review the existing methods for microarray and RNA-Seq data power
calculation. Finally, the major motivation of developing new methods will be addressed.
1.1 QUANTIFICATION OF GENE EXPRESSION
Gene expression, which is the procedure of mRNA synthesis from a set of genes, has been
extensively used in the characterization of human disease, identication of novel disease
subtypes and potential drug target for treatment. There are more than 20,000 genes in
human genome, and only a small fraction of them are actually expressed in certain cell
types and at certain times. Understanding the dynamic changes of gene expression of a
given subject is important for us to study biological process ranging from inammation to
human aging. By comparing gene expression data between dierent groups of subjects, we
can explain the activation or deactivation of pathways and the heterogeneity of diseases.
Now, the question comes that how we can quantify the gene expression. The techniques for
quantication of gene expression could be categorized into two types: (1) Candidate gene
transcriptome proling; (2) High-throughput transcriptome proling.
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1.1.1 Candidate gene transcriptome proling
The candidate gene approach starts with a given gene list of interest, ranging from hun-
dreds to thousands. Comparing with high-throughput transcriptome proling, it requires
additional expert knowledge and consequently creates bias in the study.
Conventional method for mRNA quantication by this approach is electrophoretic tech-
niques, including northern blot(1977), which is still the benchmark against other techniques.
It has advantages that the size of transcript is obtained by gel electrophoresis and it allows
for the identication of splicing variant which may be present. However, northern blots is
tedious and its sensitivity is limited by the capacity of the gel[Roth, 2002].
Later in 1989, reports of real-time PCR (rt-PCR) experiments for transcriptome analysis
were published[Burg et al., 1989]. It is generally accepted that rt-PCR produces the most
superior quantitative data due to the exquisite sensitivity and specicity of the PCR. For
many cDNA microarray data, rt-PCR could serve as the validation instead of the other way
around. While the advantage of routine microchip array is the large number of genes that
could be proled simultaneously, they also suers from high batch eect, poor sensitivity
and specicity. In comparison, though rt-PCR can only prole a smaller number of genes
(100  400), the quality of quantication is much more desirable[Schmittgen et al., 2008].
Comparing with northern blot, the assay is far more quantitative, allowing more accurate
measurements of mRNA amounts.
1.1.2 High-throughput transcriptome proling
Advances in molecular and computational biology have led to the development of powerful,
high-throughput methods for the quantication of gene expression. These tools have opened
up new opportunities in disciplines ranging from cell and developmental biology to drug
development and pharmacogenomics.
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1.1.2.1 Hybridization based approaches(Microarray) With the increased popular-
ity of high throughput technology in mid 90's, microarray became a novel tool in quantifying
genomic changes. The ability of these arrays to simultaneously interrogate thousands of tran-
scripts had led to important advances in a wide range of biological problems. These advances
include the identication of gene expression dierences between disease and healthy tissues,
and new insights into developmental processes, pharmacogenomic responses, and the evo-
lution of gene regulation. The principle of a microarray experiment is that mRNA from a
given tissue is used to generate a labelled target, which is then hybridized in parallel to a
large number of DNA sequence, immobilized on a solid surface in an ordered array[Schulze
and Downward, 2001]. The data generated from microarray experiment typically consist of
a long list of measurements for spot intensities or intensity ratios. Nonetheless, it suers
from following limitations: (1) background noise from hybridization limits the measurement
of expression, especially for probes with low abundance; (2) heterogeneity of probes with
respect to their hybridization properties will reduce the accuracy of measurements; (3) assay
is limited to transcript with relevant probes[Marioni et al., 2008].
1.1.2.2 Sanger sequencing of cDNA or EST libraries Sanger sequencing, developed
by Frederich Sanger and colleagues in 1977 [Sanger and Coulson, 1975], is a method of DNA
sequencing based on the selective incorporation of chain-terminating dideoxynucleotides by
DNA polymerase during in vitro replication. It is more desirable to be used for projects with
smaller-scale requirement for gene expression quantication.
1.1.2.3 Serial Analysis of Gene Expression (SAGE) Serial Analysis of Gene Ex-
pression(SAGE) was used to overcome the disadvantage of low throughput, expensive and
non-quantitative in Sanger sequencing. This tag-based sequencing method can provide pre-
cise and digital gene expression levels. They have, however, shortcomings, such as that, a
signicant portion of the short tags cannot be uniquely mapped to the reference genome
and only partial transcripts are covered, etc. These disadvantages have largely limited the
application of traditional sequencing technologies[Wang et al., 2009b].
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1.1.2.4 RNA-Seq With the advent of rapid Next Generation Sequencing(NGS) technol-
ogy with reduced cost, RNA-Seq was recently developed to characterize the transcriptomic
proling, impacting almost every eld in life science and is being applied for clinical use. In
general, RNA sample is converted to a library of cDNA fragments with adaptors attached
to one or both ends. Then, each RNA molecule is sequenced in a high-throughput manner
to obtain short sequences for one or both end. Once reads with high quality have been
retrieved after preprocessing, the next step for quantication of gene expression is the align-
ment to reference genome. Consequently, we can compute the number of reads that have
been aligned to each gene region[Wang et al., 2009b]. Comparing with microarray platforms,
RNA-Seq technology has many advantages. First, RNA-Seq can cover the transcription of
whole genomic region unbiasedly comparing with hybridization-based approaches. Secondly,
it renders single-base resolution in quantication of gene expression and therefore reveals the
precise location of transcription boundaries. Thirdly, it provides more information regarding
the alternative splicing to improve our understanding of genomic transcription. Furthermore,
since there's no control probe to compared with as it is in microarray, background signal
will not be an issue to reduce accuracy. Dierent from the response variable in microar-
ray, which is continuous intensity, RNA-Seq data is consist of aligned read count for each
gene. Since RNA-Seq does not have an upper limit for quantication, there will be a larger
dynamic range it could cover. RNA-Seq has also been shown to have high accuracy and re-
producibility from previous studies[Marioni et al., 2008]. Table 1 compared the advantages
and disadvantages of major biotechnologies in the quantication of gene expression.
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Table 1: Comparison between high-throughput technology in transcriptome proling
Technology Microarray cDNA or EST sequencing RNA-Seq
Technology specications
Principle Hybridization Sanger sequencing High-throughput sequencing
Resolution From several to 100bp Single base Single base
Throughput High Low High
Reliance on genomic sequence Yes No In some cases
Background noise High Low Low
Application
Simultaneously map transcribed regions and gene expression Yes Limited for gene expression Yes
Dynamic range to quantify gene expression level Up to a few-hundredfold Not practical  8,000-fold
Ability to distinguish dierent isoforms Limited Yes Yes
Ability to distinguish allelic expression Limited Yes Yes
Practical issues
Required amount of RNA High High Low
Cost for mapping transcriptomes of large genomes High High Relatively low
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1.2 DATA STRUCTURE OF MICROARRAY AND RNA-SEQ
EXPERIMENT
A genomic study typically assesses a large number of DNA sequences under multiple con-
ditions, e.g., a collection of dierent tissue samples. The resulting data after proper pre-
processing is a gene expression matrix M = fegijj1  g  G; 1  i  k; 1  j  nkg,
where the rows (G = f !g1 ; :::; !gGg) form the expression patterns of gens, the columns (S =
f !s11; :::;  !s1n1 ; :::;  !sknkg) represent the expression proles of samples, and each cell egij is the
measured expression level of gene g in sample j of group i. We assume that the genomic
study has a balanced design. If there are two groups of interest, there are n1 = n2 = N
samples in each experiment condition. In other words, subjects f !s11; :::;  !s1n1g are in group A
with xj = 1, while subjects f !s21; :::;  !s2n2g are in group B with xj = 0. See Figure 1 for the
detailed illustration.
In microarray study, egij is log2 of raw intensity or intensity ratio, which is typically
modeled as a continuous variable. For RNA-Seq data, egij is read count of gene g of subject
j in group i. And egij is frequently observed to follow over-dispersed poisson distribution.
[McCarthy et al., 2012]
In both technologies, sample size is the most inuential factor in the determination of
power. Assuming we are primarily interested in detecting dierentially expressed genes(DE
gene) between two groups, here we formally dene the sample size (N) as the number of
biological replicates in each group. For RNA-Seq data, read(or sequencing) depth, which
is proportional to total aligned reads(R), is another important factor that impact power
calculation[Rapaport et al., 2013]. It is clear that higher read depth generates more infor-
mational reads, which will increase statistical power to detect DE genes. Throughout this
thesis, we refer to read depth and coverage inter-changeably both meaning how many reads
are assigned to a particular gene.
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(a) A gene expression matrix; (b) Notations in this paper.
Figure 1: Data structure of genomic study.
1.3 BIOMARKER DETECTION IN MICROARRAY AND NGS DATA
The most important reason to generate gene expression data regardless of specic platform
is to identify the DE genes in two or more conditions. Such genes are usually detected based
on a combination of expression change threshold and p-value cuto[Rapaport et al., 2013].
Sandrine and others [Dudoit et al., 2003] provided a comprehensive review for the sta-
tistical issues that are addressed in microarray gene expression data. Elena and others
[Perelman et al., 2007] compared several alternative methods including t-test, modication
of t-test(signicance analysis model, SAM) for dierential expression analysis. In the limma
package, an empirical Bayes approach is implemented that employs a global variance esti-
mator s20 computed on the basis of all genes' variances[Smyth, 2004]. These methods are all
based on Gaussian assumption for log transformed gene expression eij.
Due to dierent characteristics, methods for detecting DE gene from RNA-Seq data is
more complicated and diverse. The methods can be splitted into three major categories:
(1) Method based on Gaussian assumption: Bloom and others[Bloom et al., 2009] applied
the t-test to the total-count normalized data. Peter and others['t Hoen et al., 2008] performed
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a square-root transformation for the total-count normalized data to stabilize the variance
and applied a t-test afterwards. In DEGseq proposed by Wang and others[Wang et al.,
2009a], it is assumed that log ratios of the counts have a normal distribution and a z-score
is calculated.
(2) Methods based on Poisson assumption: Marioni and others[Marioni et al., 2008]
proposed a Poisson log-linear model and performed likelihood ratio test (LRT) for dieren-
tial expression gene detection. They applied normalization based on total-count implicitly.
Bullard and others [Bullard et al., 2010] took an external quantile normalization step rather
than doing total-count normalization. \Poissonseq" method [Li et al., 2012] is based on Pois-
son log-linear model, and can be used to not only two-class outcome but also multiple-class
and even quantitative outcome.
(3) Methods based on negative binomial assumption: Generalized linear model based on
a negative binomial distribution has also been developed in order to deal with over-dispersed
counts in RNA-Seq data. Robinson and others[Robinson et al., 2010] developed edgeR by
extending from previous methods for SAGE data. In their method, the dispersion parameter
can be estimated for each gene or can be assumed to be common across all genes, making this
method quite exible. DESeq, developed by Anders and Huber[Anders and Huber, 2010], is
another method that imposes a negative binomial assumption and uses local regression to
estimate the relationship between the variance and the mean. baySeq[Hardcastle and Kelly,
2010] was proposed based on empirical Bayes theory. NOISeq[Tarazona et al., 2011] diers
from previous methods in that it is data-adaptive and nonparametric, and consequently
better adapts to the size of the data set.
Comparative studies [Rapaport et al., 2013] have indicated that no single method appears
to be favorable in all settings but methods based on negative binomial assumption (e.g.,
DESeq, edgeR, and baySeq) have superior specicity, sensitivities as well as good control
of false positive errors. Intawat and others [Nookaew et al., 2011] found that edgeR could
uniquely identify more dierential gene expression(DGE) than Cudi, baySeq, DESeq and
NOISeq.
9
1.4 SAMPLE SIZE, POWER, GENOME-WIDE POWER
The design issues in microarray experiment had been broadly discussed in [Kerr and Churchill,
2001, Simon and Dobbin, 2003]. Generally, design problems cover level of replication, ref-
erence design, the balanced block design, the loop design and so on, which are proposed to
address dierent research questions. One of the most common tasks of statistician requested
by investigators is the sample size and power calculation. In general, sample size is the
number of patients or other experimental units enrolled in a study, and is usually referred
as biological replicates.
In order to calculate the sample size, it is required to have some idea of the results
expected in a study. In general, the greater the variability in the outcome variable, the
larger the sample size is required to assess whether an observed eect is a true eect. On the
other hand, the more eective a tested treatment is, the smaller the sample size is needed
to detect this positive or negative eectNoordzij et al. [2009].
Traditional denition of power is based on the framework of one hypothesis testing.
Assume we are interested in testing H0 : A B = 0 against H1 : A B = 2, where A and
B are two dierent treatment groups, both of which have the same number of subjects. To
achieve a statistical power of 1 , the sample size needs to be n = (s
2
YA  YB
)(z+z)
2
( YA  YB)2 , where 
and  denotes for type I and type II error respectively. YA   YB is usually dened as eect
size, indicating the dierence between two groups of interest. s2YA  YB is the variability of
group dierence.
Data generated from genomic study are constitute of more than 20,000 probes or genes.
In this large-scale simultaneous hypothesis testing problem, with hundreds of cases consid-
ered together, we can quantify the power of detecting genomic changes by \genome-wide
power". It was also referred as expected discovery rate(EDR) in Gary and others' paper
[Gadbury et al., 2004]. Under this framework, an important question is how we can maintain
type I error since there are multiple comparisons. Family-wise error rate and False discovery
rate(FDR)[Benjamini and Hochberg, 1995] are widely used to address this problem.
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Suppose we construct the following two by two contingency table with specic G hypothe-
ses to be known in advance. The numbers G0 and G1 of false and true null hypotheses are
unknown parameters, R is an observable random variable and A0, A1, R0, R1 are unobserv-
able random variables. In the context of microarray experiment, we would like to minimize
the number R0 of false positives[Efron, 2007, Ge et al., 2009]. In this case, genome-wide
Table 2: Multiple testing framework
True hypothesis Test declaration: Number of genes
non DE DE
non DE H0 A0 R0 G0
DE H1 A1 R1 G1
Total A R G
power is dened as EDR = E(R1
G1
) = 1   1. FDR is dened as FDR = E(R0R ). In
most genomic applications, one controls FDR under a certain pre-specied threshold (e.g.,
FDR=0.05) to obtain the DE gene list. In the power calculation method throughout this
thesis, we pursue genome-wide power (EDR)under pre-specied FDR control.
1.5 COST OF RNA-SEQ EXPERIMENT
The cost of RNA-seq experiments often limits RNA-seq studies to only a small number of
replicate libraries. Many methods developed have also limitation when being applied to
small sample size. On May.28 2014, we checked the pricing of RNA-Seq experiment in the
NGS services at MD Anderson center. Sample preparation costs 572.30 dollars per sample.
Sequencing cost for HiSeq 2000 100bp pair-end reads is 2771.55 dollars per lane for external
user. For each lane, usually 300 - 400M paired-end reads could be generated which takes
11 days according to Duke institute for genome science and policy. That means, assuming
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the alignment rate is 50%, One can generate  650X coverage of RNA-Seq data if running a
sample per lane. The cost will be (572.30+2771.55) 5  $ 16700 for ve samples at 650X.
Alternatively, one can tag two samples per lane and run ten samples at  325X for 572.30
 10 +277.15 $ 19600. In our method, we will consider both sequencing cost and sample
preparation cost in the cost function.
1.6 EXISTING SAMPLE SIZE AND POWER CALCULATION METHOD
1.6.1 The use of pilot study in power calculation
In general, power calculation method could be based on information from a pilot study or
purely model-based. Model-based methods is straight-forward and more economical, while
in most cases, it will give unrealistic estimation of sample size and power. By conducting
pilot study, we can estimate variability and eect size from pilot data to infer proper sample
size and power. Especially for genomic data, pilot study is of greater importance, since there
are variability coming from biological replicates, technical replicates, experiment and batch
eects.
In this thesis, we assume a pilot study with sample size N and total read R is available
to tackle the problem of power prediction. We will also discuss the potential approach of
power calculation when there is no pilot study in the discussion part.
1.6.2 Existing Methods for microarray data Sample Size Calculation
The signicance of performing power and sample size calculation for genomic data was rstly
addressed by Mei-Ling Ting Lee.[Lee and Whitemore, 2002] They started from a common
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setting of ANOVA model in microarray data analysis:
Yb = 0 + 1(b1) + :::+ L(bL) +
LX
l=1
LX
k>l
lk(bl; bk) + :::+ b (1.1)
where l = 1; :::; L denotes a set of L experimental factors. Parameter l(bl) denotes a main
eect for factor l when it has level bl, for l = 1; :::; L; respectively. With the purposed
hypothesis test H0 : Ig = 0 against H1 : Ig = I
d for main eects, a t-statistics, F-statistics,
2 or z-statistics could be constructed for single gene under dierent study designs. Here
Ig(= Igc) is denoted as the eect of a covariate/condition c for gene g, and the non-zero vector
Id in H1 is a target vector of dierential expression levels that is expected to detect. In their
paper, ways to control multiple comparison were discussed when genes are correlated and
not correlated. Microarray studies usually involve simultaneous test of thousands of genes,
therefore the probability of producing incorrect conclusions must be controlled.
Family-wise error rate(FWER), (F = P (R0 > 0)), is discussed in details for application
in multiple comparison issues in Mei-Ling Lee's paper. Both(1)Sidak approach: assuming
independent estimation errors; and (2)Bonferroni procedure: assuming dependent estimation
errors are considered. It is obvious that the approach proposed there doesn't consider the
heterogeneity across genes, since they assumed all genes have same variance and same eect
size for alternative hypothesis. They also mentioned the possibility to solve power calculation
problem from a Bayesian perspective, where a mixture model is introduced as:
f(v) = p0f0(v) + p1f1(v) (1.2)
where p0 is the proportion of non-DE gene, and p1 = 1 p0. Here v is the summary statistics
for each gene, f0(v) is the density for non-DE component, and f1(v) is the density for DE
component. But this approach is not investigated enough until the methodological paper for
PowerAtlas[Gadbury et al., 2004].
PowerAtlas is a popular web tool for power and sample size calculation proposed by Gary
L Gadbury and others [Page et al., 2006]. They considered the variability for mean expression
and eect size across genes by directly modeling p-value distribution of test statistics. They
introduced the concept of expected discovery rate(EDR), which could be viewed as the
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average power for all genes with null hypothesis being false. Since microarray studies are
inuenced by multiple comparison issues, they also dened true positive rate(TP), true
negative rate(TN) as shown below. The notations are consistent with Table 2.
EDR = E(R1=G1) (1.3)
TP = E(R1=R) (1.4)
TN = E(A0=A) (1.5)
Assuming we have c being a binary covariate, with 0 as control and 1 as case. If iA
and iB are underlying true expression for group A and B, we want to test whether the
expression of group A and B are dierent for the ith gene with H0 : iA   iB = 0 against
H0 : iA iB 6= 0. In their power calculation procedure, they started from a set of p-values
of t-statistics to test for dierential expression based on a pilot data. This pilot data should
have similar experimental characteristics as the future data. It could either be generated in
a pilot study or from a public database. t-statistics could be written in the following form:
ti =
eiA   eiB
Sei0xi1
q
1
nA
+ 1
nB
(1.6)
where SeiAeiB =
(nA 1)S2eiA+(nB 1)S2eiB
nA+nB 2 and n = nA + nB., assuming equal variance. When the
two groups have equal sample size nA = nB = N , test statistics reduces to:
ti =
eiA   eiBp
(S2eiA + S
2
eiB
)=N
(1.7)
With the assumption that p-value distribution by DE analysis from microarray exper-
iment is a mixture of beta component and uniform component, a mixture model is tted
with p-values from ti(i = 1; :::; G). The tted model is f
(p). Then a parametric bootstrap
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procedure is performed to obtain new set of p-values with a targeted sample size N 0. Their
key step is the transformation of t-statistics by:
ti = ti
p
N 0=N (1.8)
The underlying assumption is that the group dierence of each gene remains the same
under dierent sample size. By directly modeling p-value distribution, the heterogeneity
across genes could be maintained. Besides, it is more suited for this task since thousands of
hypotheses are tested in a discovery oriented research[Gadbury et al., 2004]. However, their
method cannot be directly apply to RNA-Seq data and they didn't control FDR at xed
level by imposing arbitrary p-value cut-o instead.
1.6.3 Existing Methods for RNA-Seq data Sample Size Calculation
The greatest distinction between RNA-Seq and microarray gene expression data is the types
of expression values. Microarray has continuous intensity, while RNA-Seq data is in read
count for each gene. As a consequence, their distribution assumption diers: Gaussian as-
sumption for microarray(usually at log-intensity level), and poisson/negative binomial dis-
tribution for NGS data.
In the typical DE gene analysis, we want to compare expression level of two experimental
groups, e.g., tumor and normal groups. it is equivalent to test H0 : iA = iB or H0 :
iA
iB
= 1
against H1 : iA 6= iB or H1 : iAiB 6= 1.
1.6.3.1 Method based on Poisson assumption Many literature has discussed various
Poisson tests for this hypothesis testing: (1) asymptotic test based on normal approxima-
tion:(a)Unconstrained maximum likelihood estimate(MLE) (b)Constrained maximum likeli-
hood estimate(CMLE); (2)tests based on approximate p-value methods; (3)exact conditional
test and mid-p conditional test; (4)likelihood ratio test, and corresponding power were cal-
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culated. See [Gu et al., 2008] for a comprehensive review for poisson rate tests. Chung-I
Li and others [Li et al., 2013a] developed methods(we will call it \Poisson model" for later
reference) for sample size and power calculation, based on previous introduced poisson tests.
They used false discovery rate(FDR) for multiple comparison, which was originally proposed
by [Storey and Tibshirani, 2001, Storey, 2002].
1.6.3.2 Methods based on negative binomial assumption Poisson tests are widely
used, while it ignores the nature of over-dispersion in real sequencing data. We have re-
viewed methods to detect DE genes based on over-dispersed poisson model. Among them,
edgeR[Robinson and Smyth, 2008] and DEseq[Anders and Huber, 2010] have been two most
popular packages to perform DE analysis. Extensive comparative studies have shown the
superiority of these two tests in detecting biomarkers over other tests. But it is obvious that
the two exact tests don't have a closed form for sample size and power calculation.
Until now, there are two methods for RNA-Seq power calculation proposed: (1)RNASe-
qPower[Hart et al., 2013]; (2)Method based on exact test.[Li et al., 2013b] The two method
are similar in that they both require estimation or pre-specication of fold change, mean
counts, coecient of variation and dispersion parameter.
RNAseqPower has a basic formula:
n = 2(z1 
2
+ z)
1=+ 2
ln(2)
(1.9)
where  and  are type I error and power respectively; zx is the x quantile of standard
normal; and  is the testing target(typically fold change or eect size). These three param-
eters are required to be xed across genes or a given study, and are often determined by
external requirements.  and , which are coverage and coecient of variation(CV) between
biological replicates are gene specic. The derivation of this formula is based on a general-
ized linear model framework and is presented in their paper. In their paper, the test is only
limited to single gene level. CV is estimated by edgeR. ( = 1p

,where  is the dispersion
parameter) When considering gene collections, they simply take 0:60 (60% quantiles of CV
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as the overall CV) and quantile of depth distribution across gene for sample size calculation.
Currently, they have an R package(RNASeqPower) available. Though this method is pretty
straightforward, it has several disadvantage: (1) it does not consider multiple comparison
issue since the the power is only computed based on one single test; (2) it fails to incorporate
the variability across genes and instead uses summary statistics for eect size, dispersion,
coverage of each gene, etc.
Chung-I Li and others [Li et al., 2013b] proposed a method for power calculation based
on exact test. For single gene case, power could be calculated by:
(N; ; A; ; !; ) =
1X
eA=0
1X
eB=0
f(N!A;

N
)f(NA;

N
)I(p(eA; eB) < ) = 1   (1.10)
where ! =
d1
d0
is the ratio of the geometric means of normalization factors between group
A and B.  is the fold change. A is the average read counts in group A and f(; ) is the
proabablity mass function of negative binomial model with mean  and dispersion .
Considering collections of genes, they provide two approaches. In the rst approach, iA,
i, i can be estimated from pilot data for each prognostic gene g that are know. Then we
could use numerical method to solve the equation:
r1 =
X
i2M1
(N; g; iA; i; !;
 ) (1.11)
where  is the type I error when FDR is controlled at f. In the second approach, we can
specify a desired minimum fold change , a minimum average read count iA and a minimum
dispersion i
This method has advantages to provide ways in account for across genes heterogeneity.
However, the parameter setting is also arbitrary and not exible enough.
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1.6.3.3 Method based on Gaussian assumption \Scotty"[Busby et al., 2013] is an-
other tool recently developed for interactive power calculation. It rst assesses number of
reads required to measure a specic number of genes, then estimate the within group vari-
ance. After that, Scotty will test a matrix of dierent experimental designs. Finally, the
design with highest power under a user-specied parameter will be selected. The parame-
ters include number of biological replicate, read depth and cost. While Scotty provides novel
ways in the experimental design for RNA-seq experiment, the framework is established based
on Gaussian assumption. Statistical power is calculated based on a t-test. They argued that
by using t-test unbiased calls of dierential expression will be produced and power formula
for t-test is readily available for the computation.
To validate the prediction accuracy of power in Scotty, the authors compared Scotty with
DESeq using simulated data. They found that when sample size is small(N=2), DESeq has
more power in detecting DE genes, while sample size increases to greater than 5, t-test have
slightly greater power in detection. However, the papers did not evalutate the accuracy of
power prediction and selection of optimal experiment conguration since they didn't have a
true power surface to compared with in their simulation studies. Furthermore, they didn't
take consideration of multiple testing issue when predicting genome-wide power.
We compare the four existing methods with respect to six dierent perspectives in Table
3. According to our observation, not a single existing method can accommodate requirements
for all these criterion and in this thesis, we will develop \SeqDEsign", a method to perform
power prediction and provide practical recommendation for the optimal experimental design
under a certain constraint of budget.
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Table 3: Advantage and disadvantage of existing methods
Method characteristics Poisson Model by Li (2013) RNASeqPower by Hart (2013) Exact test by Li(2013) Scotty by Busby (2013) SeqDEsign
Use negative binomial assumption X X X
Use pilot data X X X X X
Consider sequencing depth X X X
Consider multiple comparison (FDR) X X X
Apply genome wide power calculation X X
Consider cost function by N and R X X
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1.7 MOTIVATION OF SEQDESIGN
In all, unlike power calculation of traditional microarrays, modeling NGS data not only
involves sample size and genome-wide inference, but also includes sequencing depth and
count data statistics. The optimal design is beyond one-dimensional dual problem between
sample size versus statistical power as in the traditional array scenario. Given a total budget
and pre-specied cost factors such as unit sequencing expense (e.g. sequencing cost per
million reads), sample collection cost and bioinformatics expenditure, researchers usually
seek a two-dimensional optimal decision by balancing between the number of samples and
sequencing depth, yet existing methods have intrinsic limitations. We hypothesize that:
Using advanced count-data probabilistic modeling and power calculation, balancing be-
tween sample size and sequencing depth under a xed total budget will provide optimal
genome-wide statistical power to detect dierentially expressed genes.
In this method, the optimal design involves two-dimensional factors of sample size and se-
quencing depth under the constraint of a realistic cost schedule, involving per-unit sequencing
and sample collection, etc. As a result, the solution and interpretation from optimal design
and cost-benet analysis are readily applicable to a real-world lab setting.
The following chapters will be arranged as described below. In chapter 2, we will rst
investigate the proposed power prediction method for sample size when sequencing depth
is xed. That means, for pilot data with sample size N and xed read depth R, what's
the genome-wide power in DE gene detection if N is increased to N'? We will introduce
our algorithm step by step and demonstrate the accuracy of our method in a simulation
study with parameters estimated from real data and compare to four existing methods.
Furthermore, we applied the method to real data and evaluate the accuracy of predicted EDR
curve. In chapter 3, we develop methods to include the varying read depth in the prediction
of EDR. A three dimensional EDR surface can be consequently constructed. In chapter 4,
we will discuss the design of cost function, optimization of EDR given cost function and
provide a series of case studies for cost-benet analysis. Furthermore, the predicted optimal
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design will be compared with underlying true optimal design. Finally, in chapter 5, we will
discuss several major issues and limitations of our methods and the future directions.
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2.0 SAMPLE SIZE AND GENOME-WIDE POWER(EDR) PREDICTION
As described before, genome-wide power could be modeled as an increasing function of
sample size. For RNA-seq data, many power calculation methods[Li et al., 2013a,b] were
established based on this assumption. In this chapter, we rstly investigated the inuence of
sample size on the estimation of genome-wide power, namely EDR, in our proposed methods
and then compared with existing methods in simulation studies. We further applied our
proposed method in real data applications.
2.1 HYPOTHESIS TESTING FOR DE GENE DETECTION
In chapter 1, we reviewed methods for DE gene detection under dierent models. There
are advantages and disadvantages for each method. Yet, most of them could not be directly
applied to predict power of a target sample size N' given a pilot data with sample size N in
the case of RNA-Seq data.
Here we proposed the application of Wald test based on generalized linear model for power
calculation. The statistical formulation has been discussed in detail in a recent paper[Zhu
and Lakkis, 2013]. Following our notation in chapter 1, denote by egij the read counts of gene
g(g = 1; :::; G) for subject j(j = 1; :::; ni) of group i(i = 1; 0). For example, i=0 represents
the control and n0 is the number of controls; i=1 for the case and n1 for number of cases.
Assume egij follows a negative binomial distribution with mean gij and common dispersion
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parameter , egij has the following probability mass function:
P (egij) =
 ( + egij)
 ()egij!
(
 1gij
1 +  1gij
)egij(
1
1 +  1gij
) (2.1)
where  () is the gamma function. Link function for negative binomial regression is:
log(gij) = log(Rij) + g0 + g1xij (2.2)
where Rij is assumed to be the total mappable reads for subject j in group i and xij is a indi-
cator variable(subjects x1j comes from case group(i=1) and subjects x0j comes from control
group(i=0)). From previous two formula, we can easily get the log-likelihood function:
Lg =
1X
i=0
niX
j=1
[log
 ( + egij)
 ()egij!
+ egijlog(
 1gij)  (egij + )log(1 +  1gij)] (2.3)
g0 and g1 could be estimated by standard maximum likelihood(ML) methods with proper
initial points. Variance-covariance matrix of the MLE estimates could be approximated by
inverse expected Fisher information.
For gene g, our goal is to test null hypothesis H0 : g1 = 0 against H1 : g1 6= 0. Based on
likelihood theory, asymptotic tests, including likelihood ratio test, score test and Wald test,
can be constructed. Among the three tests, only Wald test statistics could be written in a
closed form. The advantage of Wald test is the convenience for Z statistic transformation
assuming eect size of treatment remains the same for each gene for dierent sample sizes.
Specically, Wald test could be constructed by:
Zg =
^g1q
V ar(^g1)
 N(0; 1) (2.4)
under the null hypothesis for gene g. P1
i=0
Pni
j=1[egij   (egij + ) qij(1+qij) ]P1
i=0
Pni
j=1[xijegij   (egij + ) xijqij(1+qij) ]

=

0
0

(2.5)
where qij = 
 1Rijeg0+g1xij and
 ^g0
^g1

can be estimated by solving equation (2.5) by numer-
ical methods.
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For purpose of power calculation, we assume all samples have the same total reads R,
Rij = R 8 i, j . When samples do not have equal total reads, normalization methods could
be applied to meet this requirement. Under this assumption, the expected sher information
can be simplied as:
Fg =  E( @
2Lg
@(g0; g1)
) =
0@ n0Reg01+ 1Reg0 + n1Reg0+g11+ 1Reg0+g1 n1Reg0+g11+ 1Reg0+g1
n1Re
g0+g1
1+ 1Reg0+g1
n1Re
g0+g1
1+ 1Reg0+g1
1A (2.6)
Cov

^g0
^g1

= F 1g (^g0; ^g1) (2.7)
And consequently,
V ar(^g1) =
1
n0
 ( 1 + e
^g1
Re^g0+^g1
+
1 + 
^
) (2.8)
where  is n1
n0
.
Here, the dispersion parameter is assumed to be common across all genes and is estimated
by conditional maximum likelihood in \edgeR"[Robinson and Smyth, 2008]. The reason for
using common dispersion parameter is that when sample size is small, (which is usually the
case in pilot studies) estimating tag-wise dispersion parameter for each gene separately is
impractical. We could consequently compute the p-value corresponding to each Z statistics
by pg = 2 (Z  jZgj) based on the pilot data.
2.2 MIXTURE MODEL FITTING
According to the literature review in chapter 1, we saw that a lot of existing power calcula-
tion methods for RNA-seq did not consider the heterogeneity of genes with respect to gene
expression variability and eect size. Here, we want to directly model p-value distribution by
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parametric or semi-parametric model to preserve the heterogeneity. This is argued to pro-
vide a reasonable model for distribution of p-value in microarray experiment [Allison et al.,
2002], and we assume the same for RNA-seq experiment.
The idea of modeling p-value distribution from microarray study by nite parametric
mixture model was proposed by David and others[Allison et al., 2002]. Assuming indepen-
dence of gene expression levels across genes, under null hypothesis that there's no dierence
between gene expression of two groups, the distribution of p-value is Uniform(0,1) regard-
less of the test being used. Under the alternative hypothesis, on the other hand, p-value
distribution will tend to concentrate close to 0. Consequently, a useful way in presenting the
p-value distribution is by a mixture model. We call the following model as \Beta-Uniform
mixture model"(BUM model).
f(pjr; s; ) = f0(p) + (1  )f1(pjr; s); (2.9)
where f0(p) is a uniform density; f1(pjr; s) is a beta distribution density with parameter r
and s (0 < r < 1  s),  2 (0; 1) is the proportion of non-DE genes. (The constraints are
required to guarantee proper shape of beta distribution for DE genes). Figure 2 showed a
stacked histogram of p-values with red being the DE gene p-values and blue being non-DE
gene p-values from simulated data.
Here, we discussed ve alternative approaches in estimating mixture model of p-values
distribution. Among them, the rst four methods were based on BUM model with parameter
, r and s. While the fth method was based on a semi-parametric mixture model, where
density of DE component(f1) was estimated by adaptive kernel smoothing method.
(1)Three parameter BUM model: We used maximum likelihood method to estimate ; r
and s with the above constraints by \L-BFGS-B" method in R function \optim", which
allows for box constraints (each variable can be given a lower and/or upper bound). We
selected 10 initial points for optimization(9 sets of random initial and 1 set being the estimate
of Storey and Tibshirani's method for  and method of moment estimates for r and s), and
choose the solutions corresponds to the largest likelihood.
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DE gene p-value follow roughly a beta distribution and non-DE gene p-value follow a
uniform distribution.
Figure 2: Stacked histogram: p-value distribution by mixture model.
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(2)Storey and Tibshirani's method BUM model: Storey and Tibshirani [Storey and
Tibshirani, 2003] proposed an approach to estimate  though their nal goal is to compute
q-values given a set of p-values by tting function of  to a natural cubic spline.
(3)Two parameter BUM model: This model was introduced in Pounds's work. [Pounds
and Morris, 2003] The beta-uniform mixture density was constrained by s=1. So the two
parameter BUM model is :
f(pj; r) = + (1  )rp(r 1) (2.10)
This method was implemented by \Bum" in R package \ClassComparison".
(4)CDD BUM model: Ferkingstad and others [Langaas et al., 2005] proposed another
method to estimate  by nonparametric maximum likelihood. We implemented their method
by function \convest" in R package \limma". The shape parameter of beta distribution was
then estimated by maximum likelihood method.
(5) Semi-parametric BUM model: In previous work, people had observed the alternative
distribution sometimes could not be modeled by beta distribution well. So we now introduce
a semi-parametric model for p-value distribution. This is called \semi-parametric" since the
non-DE gene p-value distribution is still assume to be uniform, but the DE gene p-value
distribution will now be modeled by a non-parametric density. This is usually a decreasing
density.
Represent the mixture density as f(pj) = f0(p) + (1  )f1(p), our goal is to estimate
f^1(p). We proposed the following procedure:
1. Estimate  by Storey and Tibshirani's method;
2. Apply logit transformation: P = logit(p) to avoid boundary eect of density estimation.
The mixture model density becomes g(P j) =  eP
(1+eP )2
+ (1  )g1(P );
3. Estimate g(P j) by adaptive kernel smoothing method; [Silverman, 1986]
4. Given , compute g^1(P );
5. Transform g^1(P ) back to f^1(p).
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With any of these ve methods, we will nally come up with the tted mixture density:
f^(pj^) = ^f^0(p) + (1  ^)f^1(p) (2.11)
2.3 GENOME-WIDE POWER(EDR) PREDICTION
The ultimate goal of our approach is to predict EDR under targeted sample size(N') with
FDR controlled at false discovery rate %. Given a tted p-value mixture model, we were
able to perform a re-sampling procedure in estimating EDR. The procedure will be repeat
for many times for the power prediction. Originally, we proposed both frequentist and
bayesian approach. For the convenience of statistics transformation, we determine to use
bayesian approach described below. Since previously we had applied both parametric and
semi-parametric ways in the estimation procedure, the re-sampling method could also be
parametric sampling and non-parametric sampling(e.g., Metropolis Hasting). In both ap-
proach, we proposed method to sample DE status based on posterior probability for purpose
of power prediction.
2.3.1 Posterior sampling approach based on parametric model
We already computed the Z statistics (Z1; :::; Zg) for a given pilot data. Given tted mixture
density (2.11), we can compute posterior probability of whether a certain gene comes from
DE gene:
P (Ig = 1j^; r^; s^; pg) = (1  ^)f^1(pgjr^; s^)
(1  ^)f^1(pgjr^; s^) + ^
(2.12)
where Ig is a binary variable indicating the DE gene status. When Ig = 1, g
th gene comes
from DE component. Otherwise, it comes from non-DE component. r^, s^ and ^lambda were
estimated from mixture model tting. We then implement the following procedure:
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1. In the bth simulation, I(b) = fI(b)1 ; :::; I(b)2 ; :::; I(b)G g are randomly generated from P (Ig =
1j^; r^; s^; pg). (1  g  G)
2. Only p-values from alternative distribution will be transformed by:
Z(b)g = I
(b)
g  Zg 
r
N 0
N
+ (1  I(b)g ) Zg (2.13)
where N 0: predicted sample size. Remember that in formula (2.8), V ar(^1) could be
written as a function of sample size N. Therefore, if we assume eect size of DE gene
remains the same as sample size increases, we can apply transformation (2.13). It is
also based on the assumption that, as sample size increases, p-value of non-DE gene will
remain non-signicant, yet DE gene will be more signicant.
3. Compute p-value based on 2-sided test: p
(b)
g (I
(b)
g = 1) = 2 (1  (jZ(b)g j))
4. Control empirical FDR at %:
a. Order p-values so that: p(1)  p(2)  :::  p(j)  :::  p(G)
b. For p(j), compute FDR(p(j)) =
PG
g=1(1 I(b)g )1fp(b)g p(j)gPG
g=1 1fp(b)g p(j)g
c. p(b) = argmax
p
(b)
g
(FDR(p
(b)
g )  ), where p(b) is the p-value cut-o for bth simulated
sample.
5.\EDR
(b)
= R^1
(b)
G^1
(b) , at the mean time, we can compute: dTP (b) = R^1(b)R(b) , dTN (b) = A^0(b)A(b) , where
R^
(b)
1 =
PG
g=1 I
(b)
g 1fp(b)g <p(b)g, R^
(b)
0 =
PG
g=1(1 I(b)g )1fp(b)g <p(b)g, A^
(b)
1 =
PG
g=1 I
(b)
g 1fp(b)g p(b)g
and A^
(b)
0 =
PG
g=1(1  I(b)g )  1fp(b)g p(b)g, G^
(b)
1 = A^
(b)
1 + R^
(b)
1 , R
(b) =
PG
g=1 1fp(b)g <p(b)g, A
(b) =PG
g=1 1fp(b)g p(b)g according to Table 2.
We repeated step 15 for B=100 times and computed estimated EDR and evaluate TN rate
by averaging across the B repeats:
E^dTP =
BX
b=1
dTP (b)=B; E^dTN = BX
b=1
dTN (b)=B; E^\EDR = BX
b=1
\EDR
(b)
=B (2.14)
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2.3.2 Metropolis Hasting approach based on semi-parametric model
It has been argued that the p-value distribution of DE component sometimes does not strictly
follow beta-distribution. In that case, the application of beta distribution will be harmful to
the inference of EDR. In the previous section, we proposed ways to model p-value distribution
by semi-parametric methods to address this problem. We simulated p-value from alternative
distribution by Metropolis Hasting:
2.3.2.1 Bootstrap p-value from estimated density
1. Assuming y 2 f^1, proposal distribution is N(y; 5 V ar(y))
2. Initialize: Y0 = y
3. In each iteration t, we simulate a number(Y ) from N(y; 5  V ar(y)), and compute
acceptance probability:
r =
f^1(Y
)
f^1(Yt 1)
(2.15)
We also generate a random number u from uniform distribution Uniform(0,1). If u  r,
assign Yt = Y
, otherwise Yt = Yt 1. And tth number of generated sample is Yt 1.
4. The desirable acceptance rate is around 20  50%.
In our simulations, we generated markov chain with 20,000 steps and remove the the rst
2000 number generated. (burn in period) We implemented both (2.3.2.1) and (2.3.2.2) in
our simulation studies. Due to their similar performance, here we'll only show the result of
(2.3.2.2).
2.3.2.2 Posterior sampling approach based on semi-parametric model Similar
with parametric approach, we generated posterior probability for each p-value (2.12) based
on semi-parametric model (substitute f^1(pgjr^; s^) with f^1(pg)), and simulated DE gene status
for each bootstrap sample. After the simulation of p-values or DE status, we followed the
step (2)  (5) as in section 2.3.1.
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2.4 SIMULATION STUDIES
To mimic the real world situation, parameters of our simulation settings was based on a real
data downloaded from SRA with relatively high read depth. (http://trace.ddbj.nig.ac.
jp/DRASearch/study?acc=SRP023266) We estimated the model parameters from real data
and simulated data with some variability of the estimated parameters.
2.4.1 SRA data description and preprocessing
This SRA data was based on a rat study, where the RNA-seq data of noninfectious HIV-1
transgenic (HIV-1Tg) rat was compared with F344 control rats. [Li et al., 2013c] The primary
goal of this study was to identify dierentially expressed genes and enriched pathways aected
by the gag-pol-deleted HIV-1 genome. The authors sequenced RNA transcripts in three brian
regions (prefrontal cortex(PFC), hippocampus(HIP), and striatum(STR)) of HIV-1Tg and
F344 rats by RNA deep sequencing. A total of 72 RNA samples were sequenced (12 animals
per group  2 strains  3 brain regions). The dierential expression signal in this data set
was relatively weak, with fold change cut-o specied  20%. The nal number of declared
DE genes for the three brain regions were 197, 154, and 171 out of a total of 14,750 genes
from the original paper.
Following deep-sequencing of 50-bp paired-end reads of RNA-Seq, we used Bowtie /Tophat
/Cuinks suites(version 2.0.10) to align these reads onto gene regions based on the Rn4 rat
reference genome. Then htseq-count was used to summarize number of reads aligned to
each gene. We further applied normalization method in \EDASeq" to perform within-lane
normalization procedures to adjust for GC-content eect (or other gene-level eects) on read
counts[Risso et al., 2011].
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2.4.2 Dierential analysis and Compare Wald test with exact/likelihood ratio
test in real data analysis
To conrm the validity of Wald test when pilot sample size is small, we rst compared the
p-value distribution of Wald test and exact/likelihood ratio test performed in \edgeR". (R
function \exactTest" and \glmLRT" respectively.) Dispersion parameter  was estimated
by \estimateCommonDisp" in \edgeR". The results are shown in Figure 3.
Figure 3 indicated an almost perfect concordance of p-value distribution between (1)
Exact test vs. likelihood ratio test; and (2) Wald test vs. exact test for all three real
datasets. We tted the p-value from Wald test into three parameter BUM mixture model
for all three real datasets. Figure 4 showed the tted p-value density. (red: mixture density;
black: uniform component) p-value distributions of PFC and STR data were not ideal to be
tted into mixture parametric model, while HIP data worked well under this assumption.
2.4.3 Simulation settings
To mimic data structure in real case, we simulated data based on model estimated from real
data. We started with HIP data (N=12, R=G, G =14750,  600) since that its p-value
distribution had good tting into p-value mixture model and therefore we computed the
mean counts per gene(g) and generated data sets based on the its empirical distribution.
We also calculated log-fold-change(lfcg), which is simply, e^g1=e^g0, and lfcg was tted into
a truncated normal distribution with four dierent cut-os. Common dispersion parameter
 was estimated by \edgeR". See Table 4 for the notations for parameters in simulation
settings.
To evaluate predicted EDR under dierent simulation settings, we generated data with
slightly dierent dispersion and fold change parameters. Based on real data, we estimated
dispersion to be ^ = 50. We selected  = 40; 45; 50; 55; 60 in our simulation. In real data
analysis, we estimated mixture model parameters of p-values. ^ by Storey's method was
roughly 0.90, meaning 10% genes come from DE component. The distribution of lfc from
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(a) PFC data; (b) HIP data; (c) STR data. Left panel is Quantile-Quantile plot of p-value
from exact(x axis) and likelihood ratio test(y axis). Right panel is Quantile-Quantile plot
of p-value from exact(x axis) and Wald test(y axis).
Figure 3: Compare distribution of p-values by using Wald test and ex-
act/likelihood ratio test.
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(a) PFC data; (b) HIP data; (c) STR data.
Figure 4: p-value distribution by Mixture model
Table 4: Notations of parameters in simulation settings
Parameter Explanation
N Number of biological replicates in each group in pilot study
N' Number of biological replicates in each group in future study
G Total number of genes in pilot study
R Total number of reads for each sample in pilot study (R=G)
R' Total number of reads for each sample in future study
egij Observed reads for subject j in group i
 Average reads per genes per sample
g Average reads for gene g per sample
g1 Average reads for gene g in group A
g0 Average reads for gene g in group B
 Common dispersion parameter
m% Percentage of DE gene
lfcg log-fold-change for gene g
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DE genes followed N(0,0.04) truncated at certain cut-os. If we selected the top 10% genes
with largest lfc then the corresponding cut-o was around 0.2 (fc=1.15). We also added in
several alternative cut-os, including 0.26, 0.32 and 0.38. (corresponds to 1.2; 1.25 and 1.30
at fold change scale) In the original paper of HIP data, the reported signicance of DE gene
was dened as p0.005 (FDR0.2) with a fold change (FC)  20%, which coincided with
our selection. The average number of reads for each gene was set to be 650. ( = 650) This
corresponds to the data generated by 1 lane and with alignment rate 50%. The total number
of genes(G) is set to be 10,000. The total number of reads per sample is R=6.5M.
The simulation studies is summarized in Figure 5. The details of simulation steps to
generate data with (N, R) is as follows:
1. Randomly sample g from empirical distribution estimated from real data.
2. Generate lfc from specied truncated normal distribution
3. Assign DE gene label: generate random number rg from Uniform(0,1), if rg 0.10 then
gth gene is DE, otherwise, it is non-DE gene.
4. Generate expression value for each sample: if gth gene is DE, eg1j  NB(g  2lfcg=2; ),
eg0j  NB(g  2 lfcg=2; ); otherwise egi:  NB(g; )
We simulated 50 datasets under each simulation setting with pilot data sample size(N)
N = 2; 4; 8; 16. For each pilot data with sample size N in the left ow chart of Figure 5,
EDR was predicted for targeted sample size(N') N 0 = 5; 10; 20; 30; 40; 50; 100, which could
be denoted by TPN(N
0), TNN(N 0), EDRN(N 0). Posterior sampling procedure was repeated
for 20 times. On the right side of Figure 5, EDR(N 0) was computed from simulated data
under the target sample size (N'). The performance of power calculation was evaluated by
comparing EDRN(N
0) with EDR(N').
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Figure 5: Flowchart of SeqDEsign when predicting EDR at targeted sample size
N'
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2.4.4 Compare ROC curve of Wald test and exact test
Wald test applies to approximations (plugged-in standard deviation and chi-squared approx-
imation) and sometimes raised concerns of accuracy compared to exact test. To demonstrate
the validity of Wald test, we rst compared it with exact test under negative binomial dis-
tribution using \exactTest" function in \edgeR" package for the two simulation settings
described above. Since we know true labels of DE gene under simulation settings, we can
compare the Receiver operating characteristic (ROC) curve and area under curve (AUC) of
Wald test and exact test.
We compared the two tests in 12 of the total 20 simulation setting. (Dispersion is
choose to be 40, 50, 60; fc is choose to be  1.15,  1.20,  1.25,  1.30). In each
setting, we generated 50 datasets and performed the two tests. Pilot data sample size N
was xed as N=4. For both methods, common dispersion parameter was estimated by
\estimateCommonDisp" due to the small sample size of pilot data. Then, we performed
the two tests separately for simulated data under each setting and generated ROC curve
by comparing the declared genes with the true labels. Figure 6 show the ROC curve(with
boxplot of 50 datasets). The ROC curves of exact and Wald test almost overlapped with
each other, indicating good concordance.
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Figure 6: ROC curve comparing exact and wald test under 12 simulation settings.
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Table 5: Summary table for AUC in 12 simulation settings
fold change(fc) =40 =50 =60
Exact Wald Exact Wald Exact Wald
 1.15 0.7693(0.0099) 0.7711(0.0098) 0.7944(0.0088) 0.7967(0.0088) 0.8160(0.0098) 0.8186(0.0098)
 1.20 0.8145(0.0086) 0.8172(0.0086) 0.8401(0.0075) 0.8430(0.0075) 0.8594(0.0071) 0.8625(0.0071)
 1.25 0.8606(0.0074) 0.8631(0.0073) 0.8852(0.0074) 0.8881(0.0072) 0.9002(0.0053) 0.9032(0.0052)
 1.30 0.8983(0.0057) 0.9008(0.0057) 0.9155(0.0061) 0.9182(0.0060) 0.9293(0.0050) 0.9322(0.0048)
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Table 5 showed the mean and standard deviation of AUC for both cases. In all cases,
Wald test had slightly higher mean AUC compared with exact test in edgeR. But there was
no statistically signicant dierence between the performance of Wald test and exact test.
2.4.5 Performance of BUM model estimation methods under dierent simula-
tion settings
Previously, we introduced several alternative approaches in modeling the mixture model
of p-value distribution. In any of these methods, we performed sampling scheme for DE
gene labels based on empirical Bayes method. In each simulation setting, we computed the
True EDR curve with its point-wise condence interval by normal approximation(bounded
between 0 and 1). We compared it with predicted EDR curve and corresponding con-
dence interval. We performed simulation studies to a total of 20 settings. (4 log-fold-
change settings(lfcN(0,0.04), truncated at +/-0.20; lfcN(0,0.04), truncated at +/-0.26;
lfcN(0,0.04), truncated at +/-0.32, lfcN(0,0.04), truncated at +/-0.38) and 5 dispersion
parameter settings(=40, 45, 50, 55, 60).)
To evaluate accuracy of power prediction with dierent pilot data sample size(N) in
simulations, we generated mean squared error of the 7 data points(N'=5, 10, 20, 30, 40, 50,
100) by comparing between predicted EDR and true EDR to evaluate the ve approaches.
Figure 7  Figure 11 showed the predicted EDR when N=2 for all ve dierent ap-
proaches. We observed that Storey and Tibshirani's method BUM model and CDD BUM
model outperformed the other methods in most simulation settings. We further summarized
the performance of four approaches by mean square error(MSE) in Figure 15 and Table 6 
Table 8, where Storey and Tibshirani's method BUM model and CDD BUM model had the
best performance in most of the simulation settings. The MSE is computed by:
MSE(N) =
X
N 0
(\EDRN(N 0)  EDR(N 0))2 (2.16)
where\EDRN(N 0) is the average of predicted EDR under (N',R) given (N,R), and EDR(N 0)
is the average of true EDR.
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Figure 7: Predicted and True EDR curve for 3-parameter BUM model (N=2)
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Figure 8: Predicted and True EDR curve for Storey's method BUM model
(N=2)
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Figure 9: Predicted and True EDR curve for 2-parameter BUM model (N=2)
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Figure 10: Predicted and True EDR curve for CDD BUM model (N=2)
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Figure 11: Predicted and True EDR curve for semi-parametric BUM model
(N=2)
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Figure 12: Predicted and True EDR curve for Storey and Tibshirani's method
BUM model (N=4)
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Figure 13: Predicted and True EDR curve for Storey and Tibshirani's method
BUM model (N=8)
47
Figure 14: Predicted and True EDR curve for Storey and Tibshirani's method
BUM model (N=16)
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Five rows indicate ve dierent dispersion parameter setting: =40, 45, 50, 55, 60.
Figure 15: Compare four dierent power prediction approaches by mean square
error (MSE)
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Table 6: Summary table for MSE for simulation settings  = 40 and all lfc settings
Method N=2 N=4 N=8 N=16
3-parameter BUM model 0.0180 0.0035 0.0027 0.0031
Storey's method BUM model 0.0241 0.0040 0.0009 0.0011
Semi-parametric model 0.0145 0.0040 0.0023 0.0027
2-parameter BUM model 0.0354 0.0426 0.0425 0.0304
CDD BUM model 0.0210 0.0033 0.0007 0.0020
Due to the good performance and computation simplicity, we sticked to Storey and
Tibshirani's method BUMmodel as our approach for mixture model tting for later methods.
Figure 12, Figure 13 and Figure 14 showed the predicted EDR curve for 3 parameter BUM
model when N increases to 4, 8, 16. The accuracy of EDR prediction was improved as pilot
sample size increased.
2.5 MODEL DIAGNOSTICS
Since our EDR prediction methods depend on the tting of parametric mixture model,
it is important to evaluate the tting of mixture model in two aspects: (1) Fitting of beta
component; (2) Estimation of  by dierent methods. We focused on Storey and Tibshirani's
method BUM model and CDD BUM model due to their good performance.
2.5.1 Fitting of beta component
We compared the distribution of tted beta component with the empirical distribution of
true DE genes. Specically, we extracted the true DE genes according to underlying true
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Table 7: Summary table for MSE for simulation settings  = 50 and all lfc settings
Method N=2 N=4 N=8 N=16
3-parameter BUM model 0.0110 0.0044 0.0029 0.0031
Storey's method BUM model 0.0099 0.0035 0.0005 0.0012
Semi-parametric model 0.0084 0.0027 0.0027 0.0031
2-parameter BUM model 0.0347 0.0410 0.0367 0.0240
CDD BUM model 0.0111 0.0030 0.0024 0.0021
label and compared with the distribution of tted beta distribution f1(pjr^; s^) by Quantile-
Quantile(QQ) plot of -log10 p-values. In Figure 16, the DE gene p-value distribution was
tted well by estimated beta distribution using Storey and Tibshirani's method BUM model
according to Quantile-Quantile plot of -log10 p-value. For CDD BUM model, the tting of
beta component was good as well. (not shown here) Figure 17 showed the empirical p-value
distribution for each simulation setting when N=2. As dispersion and fold change cut-o
increased, p-value distribution of DE genes became sharper, while non-DE gene still followed
uniform distribution.
2.5.2 Estimation of 
Here we compared the estimation of  with our underlying truth ( 0.9) under dierent
simulation settings for N=2.
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Table 8: Summary table for MSE for simulation settings  = 60 and all lfc settings
Method N=2 N=4 N=8 N=16
3-parameter BUM model 0.0076 0.0027 0.0038 0.0022
Storey's method BUM model 0.0078 0.0024 0.0011 0.0009
Semi-parametric model 0.0056 0.0020 0.0014 0.0040
2-parameter BUM model 0.0337 0.0382 0.0310 0.0194
CDD BUM model 0.0079 0.0017 0.0012 0.0016
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Five rows indicate dierent dispersion parameter (1)  =40;(2)  =45;(3)  =50;(4) 
=55;(5)  =60. Four columns indicate dierent fold change cut-o (1) fc  1.15; (2) fc 
1.20; (3) fc  1.25; (4) fc  1.30.
Figure 16: Quantile-Quantile plot for 20 simulation settings
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Five rows indicate dierent dispersion parameter (1)  =40;(2)  =45;(3)  =50;(4) 
=55;(5)  =60. Four columns indicate dierent fold change cut-o (1) fc  1.15; (2) fc 
1.20; (3) fc  1.25; (4) fc  1.30.
Figure 17: p-value distribution in dierent simulation settings(N=2)
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Five rows indicate dierent dispersion parameter (1)  =40;(2)  =45;(3)  =50;(4)  =55;(5)  =60. Four columns indicate
dierent fold change cut-o (1) fc  1.15; (2) fc  1.20; (3) fc  1.25; (4) fc  1.30.
Figure 18: Lambda estimate of ve methods in dierent simulation settings(N=2)
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For all four methods,  tended to be over-estimated(Figure 18). As pilot sample size
increased, the estimation was more towards underlying truth(not shown here). To note,
CDD method actually gave the most accurate estimates among all methods, especially when
the data signal was stronger.
2.6 COMPARISON WITH OTHER EXISTING METHODS IN
SIMULATION SETTINGS
In chapter 1, we introduced several existing methods for the power calculation of RNA-Seq
data. Here, we compared our proposed method with four other methods: (1) Poisson model;
(2) RNASeqPower; (3) NB exact test; and (4) Scotty in the simulation setting when  = 50
and lfc  0:26 (fc  1.2) with N=2, 4, 8 and 16. Since the methods depends on dierent
assumptions, we need to compare them in a more reasonable way. In general, we estimated
input parameters from pilot data or provided the underlying truth if favorable to the existing
method to facilitate a fair comparison.
Similar to what we did for SeqDEsign, in all the other tests, we rst ltered out genes
with small mean counts across samples. Several cut-os for mean counts(1,2,5,8,10) were
tested and compared. The basic rule is that we want to remove a small number of genes with
shallow coverage which inuence the tting of mixture model. Through the comparison, we
determined to use 5 reads/gene as the cut-o for all simulation studies. We implemented
power calculation by Poisson model based on R code provided by Li and others[Li et al.,
2013a]. In detail, we gave it the true proportion of prognostic genes, which is around 10%
of total genes, and assumed 80% of them are true rejections, which was suggested in the
example of the original paper. The FDR was set as 0.05. We gave the true minimum DE
gene fold change 1.2 as the input parameter. We then applied RNASeqPower method by
R function \rnapower" in package \RNASeqPower". Depth was estimated by averaging the
read count align across to each gene and samples. Biological coecient of variation(BCV) was
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estimated as BCV =
p
1=0:50, where 0:50 was the 50% quantile across tag-wise dispersion
(g) estimated by \estimateTagwiseDisp" in R package \edgeR". We set eect size 1.20 and
the false positive rate 0.05. For NB exact test method, we implemented their R function
\est power" in package \RnaSeqSampleSize". The parameter setting was similar as it was
in Poisson test. We only need to additionally specied the estimate of maximum tag-wise
dispersion parameter, which was estimated by \edgeR". Lastly, we implemented \Scotty"
in MATLAB code downloaded from https://github.com/mbusby/Scotty. To compute
power, we need to provide p-value cut-o to use as the metric of power, which is simply the
declared DE gene cut-o. To make it comparable with all methods which have FDR control,
we estimated the the exact p-value cut-o corresponds to FDR at 5% for each pilot data and
input this for \Scotty". The other parameters were specied the same as other methods.
According the results in Figure 19, our method performed overall the best, especially
for power prediction when N' was smaller (N'40). When pilot sample size was two, the
prediction was a little conservative, but bias was removed if we increased pilot sample size to
N=4 or 8. As pilot sample size increased from N=2 to 4 and 8, the predicted EDR gradually
converged to true EDR curve. \Scotty" also had similar property but the convergence rate
was smaller and the prediction was not as accurate as SeqDEsign. Except for SeqDEsign,
RNASeqPower also had good accuracy for EDR prediction, but it tended to over-estimate
EDR in general. Especially for smaller N', the bias was larger. For example, when N=8, to
attain EDR of 80%, RNASeqPower required about N'=10 samples, and SeqDEsign required
N'=18 samples. Methods based on Wald test of Poisson model (A) and exact test based on
negative binomial model (C) didn't provide satisfying EDR prediction and the prediction
accuracy didn't improve as pilot sample size increased.
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(A) Poisson model; (B) RNASeqPower; (C) NB exact test; (D) Scotty; (E) SeqDEsign.
Figure 19: Method comparison for setting ( = 50 and fc 1.20).
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The three rows indicate (A) = 40;(B) = 50;(C) = 60, x axis of each gure is fc cut-o.
Figure 20: Comparisons between RNASeqPower and SeqDEsign for 12 simulation settings
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We further compared SeqDEsign with RNASeqPower in more simulation settings(Figure
20). In Figure 20, we showed the MSE of RNASeqPoewr(black circle) and SeqDEsign(red
triangle) in simulation settings with dierent N, fc cut-o(x axis) and  (three rows). Se-
qDEsign outperformed RNASeqPower in almost all simulation settings.
2.7 REAL DATA APPLICATION
We applied our method to the real data HIP by assuming dierent pilot data sample size.
We randomly sub-sampled N=2, 3, 4, 5, ..., 11, 12. (when N  10, we sub-sampled D=100
data for each case) Then we predicted EDR at N'=N, N+1, ..., 12, 20, 30, 40, 50, 100.
We observed that when pilot sample size is very small(N=2), p-value distribution didn't
strictly follow BUM model(Figure 21). For example, many p-value distribution had heavier
tail in the right hand size, In this case, if we still t the mixture model, the corresponding
EDR will be over-estimated. However, this kind of p-value distribution indicated that there
were very few DE genes in the data. We dened the mean of all p-values as p. To recognize
the p-value distribution where mixture model estimation might fail, we compared p with
0.5, which is mean of uniform(0,1). If p  0:5, this indicates p-value distribution is not
skew to the right and doesn't satisfy our model assumption. The associated EDR will be
set to 0. Follow the same procedure of EDR computation, we compared the EDR predicted
curve at each N with EDR curve generated under N=12(maximum pilot sample size). The
results was shown in Figure 22. When N  6, the EDR prediction\EDRN(N 0) seemed to
converge well to\EDR12(N 0). Although we did not know the underlying truth of EDR(N'),
in this dataset, the result reasonably suggested that N 6 was needed and SeqDEsign was
performing well.
Furthermore, we also generated results for the other methods in Figure 23. (D=10)
Poisson model and NB exact test did not not look reasonable since their predicted EDR was
only 1525% even with sample size N'=100. For RNASeqPower and Scotty, the EDR curves
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Figure 21: p-value distribution in 10 subset of real data(N=2,4,6)
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were more reasonable but the result was suspicious since they claimed similar prediction
performance for small pilot sample size(N=2) and large pilot sample size(N=12). The result
of our SeqDEsign was more reasonable in that small pilot sample size(N=2,4,6) provided
variable and inaccurate power prediction and the performance converged once the pilot
sample size was large enough (N>6).
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Figure 22: Real Data Application:SeqDEsign
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(A) Poisson model; (B) RNASeqPower; (C) NB exact test; (D) Scotty; (E) SeqDEsign.
Figure 23: Real Data Application: Compare with four existing methods
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2.8 UNBALANCED EXPERIMENTAL DESIGN
Unbalanced design is very common in genomic and clinical studies. For example, in cancer
studies, due to the homogeneity of normal samples, researchers usually recruit less subjects
in normal groups. Previously we focused on balanced design, where both groups had pilot
sample size N0 = N1 = N and the predicted sample size was N'. Now, we will investigate how
to modify existing approaches to predict EDR at targeted unbalanced studies with sample
size (N 00 and N
0
1). The prediction of unbalanced experimental design involves the change
of sample size and allocation ratio simultaneously. Accordingly, there are two alternative
approaches to realize the power prediction.
2.8.1 Down-sampling(DS) method
From a pilot study with balanced design, we will rst take sub-samples of pilot data that
have the targeted allocation ratio 0. Then, we follow the same procedure as in Chapter 2
for EDR prediction at targeted sample size.
2.8.2 Model-based(MB) method
In chapter 2, we had introduced the resampling procedure based on posterior probability.
In the bth resampling, model-based method was solely based on the following two-way Z
statistic transformation:
Z(b)g = I
(b)
g  Zg 
r
N 0  ( 1+e^g1
Re^g0+^g1
+ 1+
^
)r
N  ( 1+0e^g1
0Re^g0+^g1
+ 1+
0
0^
)
+ (1  I(b)g ) Zg (2.17)
where  is the allocation ratio of pilot data and 0 is the allocation ratio for targeted design.
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2.8.3 Simulation study
We conducted a simulation study to test for the EDR prediction of unbalanced design. In this
setting, =50 and fc  1:20. We started with pilot data in balanced design (N=4,8,16) and
wanted to predict EDR in unbalanced design (N 01 = 2 N 00 and N 00 = 8; 10; 12; 20; 30; 40; 50).
Under this simulation setting, we generated 50 datasets. Resamping procedure was repeat
for B=50 times. We compared the performance of Down-sampling and Model-based method
for those simulation settings.
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(A) Model-based method; (B) Down-sampling method.
Figure 24: Predict EDR of unbalanced experimental design
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Table 9: Summary table for MSE of (A) Model-based and (B) Down-sampling method
Method N=2 N=4 N=8
Model-based 0.00365 0.00060 0.00028
Down-sampling 0.00419 0.00204 0.00075
SeqDEsign 0.0182 0.0174 0.0168
Figure 24 showed the performance of methods for the two approaches. (A) is model-
based method and (B) is Down-sampling approach. The x axis (N) is the sample size for
predicted case group. Since allocation ratio is constant(2), control group sample size is N/2.
In terms of MSE as indicated in Table 9, the two methods had similar good performances
in predicting EDR of unbalanced design. For computational convenience, consistency to our
previous approach and slightly better performance, we will adopt the model-based approach
for unbalanced design.
We further compared model-based approach with RNASeqPower which can also predict
power of unbalanced design under the simulation model. Figure 25 indicated that our method
had better performance.
68
Figure 25: Comparison between SeqDEsign and RNASeqPower under unbalanced design setting
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2.9 SUMMARY AND DISCUSSION
In this chapter, we have proposed and compared several alternative approaches to predict
EDR at targeted sample size(N') based on a pilot data (N, R). By evaluating each method in
terms of MSE, we found that Storey and Tibshirani's method BUM model and CDD BUM
model gave us overall best EDR prediction. We further compared Storey and Tibshirani's
method BUM model with four other existing methods. Our proposed methods gave asymp-
totically best EDR prediction as pilot sample size increased. Even when pilot sample size
was small (e.g., N=2), the prediction was only a little bit conservative which was acceptable.
In the comparative study with four other methods, our methods performed overall best in
the simulation settings.
For parametric model tting, originally we also proposed parametric bootstrap approach
as in PowerAtlas[Gadbury et al., 2004]. But since posterior approach had similar and better
performance and is more convenient for two way EDR prediction, we decided to adopt
posterior approach.
Our methods showed superior characteristics over existing methods in the investigation of
EDR prediction of targeted sample size. To design a practical algorithm of power calculation
for RNA-Seq, we will also take consideration of the read depth in the EDR computation in
the next chapter.
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3.0 SAMPLE SIZE, READ DEPTH AND GENOME-WIDE POWER
PREDICTION
So far, we have investigated the genome-wide power prediction in the direction of increas-
ing sample size. For Next Generation Sequencing data like RNA-Seq, higher read depth
generates more reads, which increases the statistical power to detect DE genes [Liu et al.,
2013, Tarazona et al., 2011]. Therefore, it is important that power calculation method
should consider the impact of read depth, yet only two existing methods (RNASeqPower
and Scotty) included this impact factor. Given the superior performance of SeqDEsign, we
now further extend the current framework to predict EDR in various read depth selections.
In this chapter, we will rst discuss two alternative approaches proposed and compare their
performance. By tting two-way inverse power law model, we will construct 3-dimensional
predicted power surface. A consequent cost benet analysis of optimal experiment design
based on this 3-dimensional power surface will be discussed in chapter 4.
3.1 NESTED DOWN-SAMPLING(NDS) AND MODEL-BASED(MB)
APPROACH FOR GENOME-WIDE POWER PREDICTION FOR A
FUTURE READ DEPTH
Here we proposed and compared two approaches to extend power calculation to two-dimensional
EDR prediction including both sample size and sequencing depth (i.e.\EDR(N;R)(N 0; R0)).
The rst approach is nested down-sampling(NDS) procedure and the other approach is
71
model-based(MB) method. In both methods, we used Storey and Tibshirani's method in
mixture model tting.
3.1.1 Nested down-sampling(NDS) method
Suppose we start with pilot data with sample size N and read depth R = 650G. We can
write the data matrix as S = f !s01; :::; !s0N ; :::; !s11; :::; !s1Ng. Each sample is consist of G
elements, each presenting the read counts aligned to a certain gene. For subject i in group
j,  !sij = fe1ij; :::; egij; :::; eGijg. We can expand all reads into a larger pool by rewriting
 !sij = f1; :::; 1| {z }
e1ij
; 2; :::; 2| {z }
e2ij
; :::; G; :::; G| {z }
eGij
g, indicating which gene each read is coming from. We
would then sample p% of reads without replacement from  !sij and collapse the reads into
gene level again so the resulting sample is spij. We could further perform downward sampling
from spij and repeat the procedure to generate sample with smaller read depth. Following
this fashion, we can represent the nested samples as  !sij650,  !sij500, !sij400, !sij300, !sij200, !sij100. The
superscript indicates the average coverage for each gene. Then we can follow the same steps
as proposed in chapter 2.3 and Figure 5. If we represent the pilot data as S: N  R, we
rst down-sample it to S':N  R' and then estimate\EDR(N;R0)(N 0; R0) and compared with
\EDR(N 0; R0).
3.1.2 Model-based(MB) method
While the nested downward sampling approach is more straightforward, it requires more
computation time since we need to repeat the subsampling procedure for multiple times,
followed by repeated sampling of DE gene status. Besides, nested downward sampling pro-
cedure could only predict EDR at R'  R. We have to applied surface tting procedure to
get predicted EDR at R'  R. In comparison, an easier way is to modied our previous
posterior procedure in the statistics transformation step. The underlying assumption is that
estimate of g0 and g1 will not be changed with sample size and read depth.
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Suppose we have a pilot data with sample size N and read depth R. If we perform the hy-
pothesis testing for each gene g with Z statistics Z
(b)
g in the bth simulation, the transformation
step is achieved by applying the following transformation:
Z(b)g = I
(b)
g  Zg 
p
N 0  ( 1+e^g1
Re^g0+^g1
+ (1+)
^
)
p
N  ( 1+e^g1
R0e^g0+^g1
+ (1+)
^
)
+ (1  I(b)g ) Zg (3.1)
After computation of the transformed Z statistics, we can follow the proposed steps to
compute predicted EDR(Pow(N',R')).
3.2 TWO-WAY INVERSE POWER LAW SURFACE FITTING
Inverse power law model is frequently tted to model learning curve created by a small
training dataset in the machine learning eld. Curve tting is carried out by nonlinear least
square optimization[Figueroa et al., 2012]. Here we propose two-way inverse power law curve
tting to model the power surface by a function of sample size and read depth. The power
function could be written as:
EDR = Pow(N 0; R0) = a  bN 0 c   dR0 e (3.2)
where a,b,c,d,e are all positive numbers. As N and R increase to innity, EDR will be
approximate to 1. Therefore, we constrain a to be 1 exactly. Specically, we estimate the
remaining four parameters by R function \optim" in \stats" R package using BFGS quasi-
Newton method. For NDS method, by tting two-way inverse power law, we can extrapolate
EDR of experimental design with higher read depth(R'> R) than the pilot data.
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3.3 SIMULATION STUDIES
3.3.1 Simulation settings
The owchart of SeqDEsign for two way EDR prediction was shown in Figure 26. As
described previously, here we want to compare two approaches to predict EDR(N',R'): (1)
Nested downward sampling; (2) Transformation of statistics in bootstrapping step.
In simulation studies, we followed the similar settings as in chapter 2. The pilot data
was generated with sample size N=2, 4 and 8 with dispersion parameter =40, 50, 60. In
each combination of N and R, we had four dierent log-fold-change cur-o for DE genes.
(0.2, 0.26, 0.32 and 0.38) The read depth of pilot data was xed at R=G650. (G=104)
To generate the true EDR curve, we simulated data under each predicted setting (N',R').
N' were selected to be 5, 10, 20, 30, 40, 50, 100, and R' were selected to be 1M, 2M, 3M,
4M, 5M, 6M, 6.5M(pilot), 7M, 8M, 9M, 10M, 11M and 12M. In each pilot data setting,
D=10 data were generated. For true data, we also generated D=10 data follow the same
distribution. Posterior procedure was repeated for B=20 times.
3.3.2 Comparisons between Model-based and Nested down-sampling method
We rst compared the predicted EDR and true EDR by mean square error without surface
tting. For Model based method, MSE under pilot study (N,R) was computed as
MSE(N;R) =
X
N 0;R0
(\EDR(N;R)(N 0; R0)  EDR(N 0; R0))2 (3.3)
For Nested down-sampling method, MSE under pilot study (N,R) was computed as
MSE(N;R) =
X
N 0;R0
(\EDR(N;R0)(N 0; R0)  EDR(N 0; R0))2 (3.4)
,where\EDR(N;R)(N 0; R0) is the average of predicted EDR under setting (N',R'), and EDR(N 0; R0)
is the average of true EDR.
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Figure 26: Flowchart of SeqDEsign when predicting EDR at targeted sample
size N' and read depth R'
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(A)N=2; (B)N=4; (C)N=8; (D)N=16.
Figure 27: Compare between MB and NDS(fc1.15)
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(A)N=2; (B)N=4; (C)N=8; (D)N=16.
Figure 28: Compare between MB and NDS(fc1.20)
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(A)N=2; (B)N=4; (C)N=8; (D)N=16.
Figure 29: Compare between MB and NDS(fc1.25)
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(A)N=2; (B)N=4; (C)N=8; (D)N=16.
Figure 30: MB and NDS(fc1.30)
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Figure 27  Figure 30 showed the MSE of two methods comparing with predicted true
EDR under dierent simulation settings(4 dierent fc cut-o) separated by N'(MSE(N,R,N')).
PS is nested down-ward sampling method and PS.2 is model-based method. Overall, model-
based method has smaller MSE in more scenarios comparing with nested down-sampling
method and have several appealing advantages: (1) it gives better EDR prediction; (2) it is
computationally more ecient; (3) it could predict EDR at a wider range of read depth.
3.3.3 Inverse power law tting
Our ultimate goal is to predict best optimal experimental design(N*,R*) for RNA-Seq.
Therefore, it's necessary for us to predict EDR surface, which is a function of N and R.
Here, given the estimated EDR from model-based method, we tted two-way inverse power
law previously proposed. Under each simulation setting, we have D=10 pilot data simulated
from same underlying model. Then ten predicted EDR surface could be constructed.
Figure 31 showed the Goodness-of-t of inverse power law tting for predicted EDR
surface, true EDR surface and third column is the MSE of predicted EDR surface comparing
with true EDR surface. The EDR surface tting for predicted EDR and true EDR was
pretty good. There was however a bump in MSE between predicted EDR surface and true
EDR surface when pilot sample size N=8 (A). After diagnosis of the problematic data, we
found that there're some problem about the mixture model tting when using Storey and
Tibshirani's method under certain situation settings. Due to the previous equally good
performance of CDD method, we also tried this approach. It estimated  by non-parametric
method and the resulting EDR prediction was shown in Figure 32. The result was much
better without any outliers.
3.3.4 Fitted EDR surface
Here we demonstrate the EDR surface prediction in several examples. Figure 33(N=2),
Figure 34(N=4) and Figure 35(N=16) are 3 dimensional plots with both true EDR sur-
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(A)fc1.15; (B)fc1.20; (C)fc1.25; (D)fc1.30.
Figure 31: Goodness-of-t of inverse power law tting model(Storey and Tishi-
rani's method)
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(A)fc1.15; (B)fc1.20; (C)fc1.25; (D)fc1.30.
Figure 32: Goodness-of-t of inverse power law tting model(CDD)
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face(red) and predicted EDR surface(green). The increment of pilot study sample size
helps the EDR prediction according to our results. The estimated true EDR surface is
Pow(N 0; R0) = 1   21:07590  N1:595355   106  R1:173074, while predicted EDR surface for
N=2 is[Pow(N 0; R0) = 1   16:3058  N1:75834   106  R1:151303, for N=4,[Pow(N 0; R0) =
1   24:97404  N 1:778650   106  R 1:137705, and for N=16,[Pow(N 0; R0) = 1   41:23273 
N 1:862118   106 R 1:136118
3.4 SUMMARY
In this chapter, we extended EDR prediction to the direction of read depth and constructed
3-dimensional power surface by inverse power law tting. Comparing with underlying true
EDR surface, our method had fairly good EDR prediction. Model-based method had advan-
tages of better prediction accuracy, wider EDR prediction coverage and higher computational
eciency compared with nested down-sampling approach. We will adopt the model-based
approach in the later sections and the software package.
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red surface-True EDR; green-Predicted EDR.
Figure 33: Compare true EDR and predicted EDR surface(=50,fc1.20,pilot
N=2)
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red surface-True EDR; green-Predicted EDR.
Figure 34: Compare true EDR and predicted EDR surface(=50,fc1.20,pilot
N=4)
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red surface-True EDR; green-Predicted EDR.
Figure 35: Compare true EDR and predicted EDR surface(=50,fc1.20,pilot
N=16)
86
4.0 COST BENEFIT ANALYSIS FOR RNA-SEQ EXPERIMENT
In RNA-Seq experiment, we usually have limited budget, which brings us to develop methods
for power calculation in designing a powerful and aordable experiment in detecting DE
genes. Therefore, it's important to design the cost function and generate the optimal design
given cost constraints. In this chapter, we further dened a reasonable cost function. Based
on tted three dimensional EDR surface and cost constraints, we conducted cost-benet
analysis to compute the optimal design. By comparing our predicted optimal design with
the underlying true optimal design in simulation studies, we demonstrated the superiority
of our method. We also discussed ways to predict desirable experimental design to meet
certain criteria (a EDR lower bound, sample size upper bound, etc.) when there is no clear
constraint of cost function. Specically, we want to answer the following practical questions
about desirable experiment design (N*,R*):
Q1: With a xed maximum total cost C, what is the optimal design?
Q2: To reach a certain EDR level (EDR'), what are all possible experimental design?
Q3: With a maximum sample size Nmax and a targeted EDR (EDR') to reach, what are
all possible experimental design?
Q4: Given a dataset with (N,R) from a RNA-Seq experiment, is it worthwhile to increase
the sample size or sequencing depth?
We designed cost functions and provided visualization tools to assist users to select the
optimal experiment design according to their specic needs.
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4.1 DESIGN OF COST FUNCTION
A reasonable cost function C could be dened as follows:
C = B(N 0; R0) = 2N 0  (A+B R0=106) (4.1)
Here N' is the targeted sample size for each group and R' is targeted total reads. To give
better interpretation, here we divide R' by 106. So A is the sample collection cost per
sample(which includes cost to recruit a patient, collect and preprocess the sample and parify
mRNA etc.), and B is the sequencing cost for per sample per million aligned reads. We use
A=$570; B=$400 throughout this section to demonstrate the method.
4.2 OPTIMAL EXPERIMENT DESIGN WITH COST CONSTRAIN
With the cost function dened previously and the tted three dimensional EDR surface
by two-way inverse power law, we can compute optimal RNA-Seq experiment design under
cost constraints. Below, we showed one simulation example of the computation of optimal
design(N,R).
Figure 36 showed the tted three dimensional power surface. Both power and cost are
increasing functions of N and R. (EDR=Pow(N,R) and C=B(N,R)) There is a requirement
that the total cost of RNA-Seq experiment should not exceed Cmax. When cost function
intersects with power surface, the experimental design corresponds to the optimal power is
the optimal design.
(N(C); R(C)) = argmax
N 0;R0;C<2N 0(A+BR0=106)
(a^  b^N 0( c^)   d^R0( e^)) (4.2)
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Figure 36: Three dimensional power surface
4.3 SIMULATION
We have conducted cost benet analysis based on simulation settings in chapter 3, when
 = 50, fc1.15;1.20;1.25;1.30, and N=2,4,8.
To address Q1 previously discussed, here we dened the cost function as in (4.1). The
total cost C was set to be 80,000. Figure 37 showed the result of optimal design under each
setting. In each sub-plot, the red curve is the cost function, orange star is the pilot study
design and purple star is the true optimal experimental design computed from simulated
true data. There are another 10 dots, which indicated our predicted pilot study design
from 10 pilot datasets simulated from the sample model. In all settings, the optimal design
predictions were pretty accurate. With increase of pilot data sample size, the accuracy of
optimal design prediction also improves.
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(A)fc1.15; (B)fc1.20; (C)fc1.25; (D)fc1.30.
Figure 37: Optimal Design given pilot study and cost function
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To illustrate the solution to Q2Q3, now we focus on setting (=50,fc1.20,N=4), where
the EDR surface is: [Pow(N 0; R0) = 1   32:588  N1:998   106  R 1:150. We now ask the
following specic questions:
(a) What experimental design(N*,R*) are favored to reach EDR' (for example, 80%,
90%)? In Figure 38, we showed the predicted power under each experimental design. The
red lines indicates boundary of desirable design with power greater than EDR'.
(b) What experimental design(N*,R*) are favored to reach EDR' (for example, 80%,
90%) with maximum sample size Nmax? Assume Nmax is 30, Figure 39 showed the resulting
desirable designs:
Now assuming that we already have a RNA-Seq dataset with (N'=8,R'=6:5 106). The
question is that if we have already achieve our desirable power EDR' (for example, 80%),
and if we need to sequence extra samples to reach that?
To answer the question, we rst computed the predicted EDR at N'=8, which is EDR'=34%.
With xed R'=6.5M, we then computed the minimum samples required to reach EDR=80%,
which is 14. (Figure 40)
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Figure 38: Desirable experiment design with constraint on minimum EDR
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Figure 39: Desirable experiment design with constraint on minimum EDR and
maximum N
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Figure 40: Desirable experiment design for a given RNA-Seq experiment
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5.0 DISCUSSION AND FUTURE WORK
5.1 DISCUSSION
In the existing and our methods, the denition of power actually varies. In SeqDEsign, we
focused on genome-wide power, which is similar to the concept of sensitivity (recall rate or
true positive rate(TPR)) in ROC analysis. We conducted more than 10,000 hypothesis tests
simultaneously and estimate genome-wide power as the proportion of true positive among the
true DE genes. It's dierent from the concept of power as in RNASeqPower, where only one
test is conducted conceptually for the computation of power. To our knowledge, genome-wide
power denition is more appropriate for the case of genomic data since the heterogeneity
across genes could be maintained. Consequently, it's somewhat unfair to compare these
dierent denitions of \power" together. But it's already the best we can do to conduct the
comparison.
In our method, we dened R as the total reads from a pilot study. To be more specic,
this should be the total reads that could be mapped to gene regions. Consequently, when
considering the sequencing cost, one should divide B by the average alignment rate to be
realistic.
As is briey mentioned in chapter 3, when we have a relatively some parameter space of
(N',R') for optimal experiment design, we can compute EDR of all possible design(EDR(N;R)(N
0; R0))
under the constraints. In this scenario, we do not have to t two-way inverse power law
model. In cases when we have a much larger parameter space to search through, for ex-
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ample, Nmax is 100 or there is very weak signal for DE gene detection, we should instead
estimated EDR at selected (N',R') to reduce computation time and apply the inverse power
law model.
Our method can predict EDR hyperplane when a pilot data is available. If there's no
pilot data, one can seek previous public datasets with similar platforms. Another possible
solution is to design RNA-Seq experiment in multi-phases. We can therefore estimated EDR
adaptively after the completion of each phase with higher accuracy.
5.2 FUTURE WORK
Here we discuss future works and directions for SeqDEsign:
FW1: Relax common dispersion assumption: Currently, our method is based on negative
binomial model with common dispersion across genes. To accommodate all possible data
structure, the next step will be to evaluate our method in data with tag-wise dispersion and
extend our method if necessary, for example, we can apply empirical Bayes methods. We
will provided test to determine whether common dispersion model is correct.
FW2: Further investigation in semi-parametric method: In the real data example of
chapter 2(Figure 21), we observed that when dierential expression has very weak signal, p-
value distribution of data with small pilot sample size(N) will not satisfy our mixture model
assumption well. In this case, the performance of our method is not good due to model
mis-specication. One solution is to apply non-parametric method. We will have further
investigation in non-parametric approach under this scenario in the future.
FW3: Design of pilot study: So far, we have illustrated the impact of sample size and
read depth to power by simulation studies and real data examples. The inuence of dierent
pilot data to the prediction of EDR surface, however, is not investigated suciently. For
example, if we specify a cost upper bound of $24,000 for pilot study. The following three
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setting of pilot study design have same cost: (a) N=4, R=6M; (b) N=8, R=3M; (c) N=16,
R=1.5M. By the three dierent pilot study, we will have dierent EDR surface predictions.
In future study, we will provide suggestions for the design of pilot study.
FW4: More real data applications: In the future, we will apply our method to TCGA
RNA-Seq data https://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp. It is a rich database
with more than hundreds of tumor samples for each cancer. We can start with various
smaller pilot sample size, generate the predicted EDR hyperplane and compared with the
\true" EDR hyperplane generated by using data with larger sample size and evaluate their
performance.
FW5: Software preparation: We will prepare an R package \SeqDEsign" and a web
interactive tool based on java script, which could facilitate the application of our tool in real
world RNA-Seq experiment.
97
6.0 CONCLUSION
Power analysis is of great importance in study design phase. Especially, with accruing
popularity of next generation sequencing technology, there's an increasing need for statistical
solid and easy-to-implement power calculation method. Some existing power calculation
tools for microarray and NGS ignore genome-wide false discovery rate control and only
perform per-gene power calculation. Some others have utilized nave modelling without
adequately borrowing information from pilot data.
In this thesis, we have proposed a new approach: SeqDEsign to predict genome-wide
power based on a RNA-Seq pilot study. Simulation studies and real data application showed
the superiority of our methods. Our approach provides several unique advantages over all
existing methods: (1) higher statistical reliability: our model is based on negative bino-
mial assumption of count data instead of poisson or gaussian assumption; (2) genome-wide
power(EDR): we dene genome-wide power(EDR) which considers the DE gene detection
sensitivity in the realm of whole genome, instead of single gene level; (3) better accuracy:
simulation and real data analysis reveals the high accuracy of our methods; (4) optimal exper-
iment design: we consider the inuence of both sample size and read depth on genome-wide
power. Consequently, given the cost constraints, one can predict the optimal experiment de-
sign (N*,R*) after EDR surface was constructed; (5) easy to implement: our method tends
to be model-based compared with existing methods. We don't need to specify fold change
for DE gene detection or number of true rejections.
To our knowledge, SeqDEsign is the rst statistical tool that address the power calcula-
tion and experimental design for RNA-Seq data with proper model assumptions. Considering
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the superior performance and capability in answering various research questions, we believe
it will provide researchers valuable suggestions in the experiment design of RNA-Seq data
in the future.
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